What is NDC 27241-110?

27241-110 is the product NDC for Ranitidine, Ranitidine hydrochloride 300 mg/1 capsule, listed with the FDA by Ajanta Pharma USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ranitidine?

12 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ranitidine NDC 27241-110 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-110Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0110Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-110-03	2724101100327241011003	30 CAPSULE in 1 BOTTLE (27241-110-03)Marketed from Sep 27, 2018
27241-110-10	2724101101027241011010	100 CAPSULE in 1 BOTTLE (27241-110-10)Marketed from Sep 27, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ranitidine
Generic name (nonproprietary): ranitidine
Active ingredients: Ranitidine hydrochloride — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Ajanta Pharma USA Inc.NDC labeler code 27241
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209859
Marketing start: Sep 27, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 27241-110_d7fd99da-f17a-4124-9014-70bbe43d78f6SPL ID d7fd99da-f17a-4124-9014-70bbe43d78f6SPL set ID fb67e8c7-b817-4253-a1a1-5ecdcee694cfRxCUI 198190, 198192UNII BK76465IHMUPC 0327241110030, 0327241109065
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241011003 followed by a unit qualifier and the quantity

Package 27241-0110-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 24, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ranitidine capsules are indicated in: Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. No placebo-controlled comparative studies have been carried out for periods of longer than 1 year. The treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome and systemic mastocytosis). Short-term treatment of active, benign gastric ulcer. Most patients heal within 6 weeks and the usefulness of…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 27241-110

What is NDC 27241-110?: 27241-110 is the product NDC for Ranitidine, Ranitidine hydrochloride 300 mg/1 capsule, listed with the FDA by Ajanta Pharma USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ranitidine.
What is the active ingredient?: Ranitidine hydrochloride.
Who is the labeler?: Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ranitidine?: 12 other product NDCs are listed under this name. See all Ranitidine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ranitidine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Atland Pharmaceuticals, LLC	71993-314	71993-0314-30
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Atland Pharmaceuticals, LLC	71993-315	71993-0315-30
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-636	64980-0636-03
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-637	64980-0637-03
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Granules India Ltd	62207-773	62207-0773-3662207-0773-4162207-0773-47+1 more
Ranitidine	Ranitidine hydrochloride 150 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-109	27241-0109-0627241-0109-50
Ranitidine	Ranitidine 15 mg/mL	SyrupOral	Pharmaceutical Associates, Inc.	0121-0727	00121-0727-16
Ranitidine	Ranitidine 15 mg/mL	SyrupOral	Pharmaceutical Associates, Inc.	0121-4727	00121-4727-10
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	53746-253	53746-0253-0153746-0253-0553746-0253-10+2 more
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	53746-254	53746-0254-0153746-0254-0253746-0254-30

All 13 Ranitidine NDCs

Other NDCs under ANDA 209859

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209859
Product	Strength	Form · route	Labeler	Product NDC
Ranitidine	Ranitidine hydrochloride 150 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-109